Table 1 Susceptibility profile of the 113 Pseudomonas aeruginosa clinical isolates
Antimicrobial agent | MBL (n = 18), susceptible isolates (%) | Non-MBL (n = 95), susceptible isolates (%) |
|---|---|---|
Meropenem | 0 | 85 |
Piperacillin-Tazobactam | 0 | 83 |
Ciprofloxacin | 0 | 78 |
Ceftazidime | 0 | 95 |
Colistin | 100 | 100 |
Amikacin | 0 | 96 |
Fosfomycin | 0 | 40 |